ATE425791T1 - Kombination aus itriglumid und ppi zur behandlung von gastrointestinalen- und assozierten krankheiten - Google Patents
Kombination aus itriglumid und ppi zur behandlung von gastrointestinalen- und assozierten krankheitenInfo
- Publication number
- ATE425791T1 ATE425791T1 AT05107042T AT05107042T ATE425791T1 AT E425791 T1 ATE425791 T1 AT E425791T1 AT 05107042 T AT05107042 T AT 05107042T AT 05107042 T AT05107042 T AT 05107042T AT E425791 T1 ATE425791 T1 AT E425791T1
- Authority
- AT
- Austria
- Prior art keywords
- gastrointestinal
- treatment
- combination
- itriglumide
- ppi
- Prior art date
Links
- MFOOVZCXWVAWOV-RUZDIDTESA-N (3r)-5-[2-(8-azaspiro[4.5]decane-8-carbonyl)-4,6-dimethylanilino]-3-naphthalen-1-yl-5-oxopentanoic acid Chemical compound C=1C(C)=CC(C)=C(NC(=O)C[C@H](CC(O)=O)C=2C3=CC=CC=C3C=CC=2)C=1C(=O)N(CC1)CCC21CCCC2 MFOOVZCXWVAWOV-RUZDIDTESA-N 0.000 title abstract 2
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 229950001743 itriglumide Drugs 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940126409 proton pump inhibitor Drugs 0.000 abstract 1
- 239000000612 proton pump inhibitor Substances 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05107042A EP1747800B1 (de) | 2005-07-29 | 2005-07-29 | Kombination aus Itriglumid und PPI zur Behandlung von gastrointestinalen- und assozierten Krankheiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE425791T1 true ATE425791T1 (de) | 2009-04-15 |
Family
ID=35351644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05107042T ATE425791T1 (de) | 2005-07-29 | 2005-07-29 | Kombination aus itriglumid und ppi zur behandlung von gastrointestinalen- und assozierten krankheiten |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7846921B2 (de) |
| EP (1) | EP1747800B1 (de) |
| JP (1) | JP2009502867A (de) |
| AT (1) | ATE425791T1 (de) |
| AU (1) | AU2006274905B2 (de) |
| CA (1) | CA2616941C (de) |
| DE (1) | DE602005013372D1 (de) |
| ES (1) | ES2324354T3 (de) |
| WO (1) | WO2007014872A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110280941A1 (en) * | 2008-12-11 | 2011-11-17 | Mefford Scientific, Llc | Compositions of proton pump inhibitors and insulin secretagogues, and methods of their use to treat diabetes |
| CN104114169A (zh) * | 2011-12-16 | 2014-10-22 | 阿托佩斯治疗有限公司 | 用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物 |
| RU2693484C1 (ru) | 2013-11-22 | 2019-07-03 | СиЭль БАЙОСАЕНСИЗ ЭлЭлСи | Антагонисты гастрина для лечения и профилактики остеопороза |
| SG10202102125SA (en) * | 2014-04-30 | 2021-04-29 | Yufeng Tseng | Use of known compounds as d-amino acid oxidase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993012817A1 (en) * | 1991-12-20 | 1993-07-08 | Warner-Lambert Company | Therapeutic combinations useful in the treatment of gastroesophageal reflux disease |
| SE9702000D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Ab | New pharmaceutical formulation |
| CA2526566A1 (en) * | 2003-05-27 | 2004-12-09 | Altana Pharma Ag | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
-
2005
- 2005-07-29 AT AT05107042T patent/ATE425791T1/de not_active IP Right Cessation
- 2005-07-29 EP EP05107042A patent/EP1747800B1/de not_active Expired - Lifetime
- 2005-07-29 DE DE602005013372T patent/DE602005013372D1/de not_active Expired - Lifetime
- 2005-07-29 ES ES05107042T patent/ES2324354T3/es not_active Expired - Lifetime
-
2006
- 2006-07-24 CA CA2616941A patent/CA2616941C/en not_active Expired - Fee Related
- 2006-07-24 AU AU2006274905A patent/AU2006274905B2/en not_active Ceased
- 2006-07-24 JP JP2008523344A patent/JP2009502867A/ja active Pending
- 2006-07-24 WO PCT/EP2006/064567 patent/WO2007014872A1/en not_active Ceased
- 2006-07-24 US US11/575,264 patent/US7846921B2/en not_active Expired - Fee Related
-
2010
- 2010-11-01 US US12/916,911 patent/US20110045033A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2616941A1 (en) | 2007-02-08 |
| DE602005013372D1 (de) | 2009-04-30 |
| EP1747800A1 (de) | 2007-01-31 |
| AU2006274905B2 (en) | 2011-08-18 |
| US7846921B2 (en) | 2010-12-07 |
| WO2007014872A1 (en) | 2007-02-08 |
| AU2006274905A1 (en) | 2007-02-08 |
| US20080004303A1 (en) | 2008-01-03 |
| JP2009502867A (ja) | 2009-01-29 |
| ES2324354T3 (es) | 2009-08-05 |
| EP1747800B1 (de) | 2009-03-18 |
| CA2616941C (en) | 2014-01-21 |
| US20110045033A1 (en) | 2011-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201170624A1 (ru) | Изоникотинамидные антагонисты рецепторов орексинов | |
| ATE538650T1 (de) | Cannabinoid-rezeptor-antagonisten / inverse agonisten zur behandlung von übergewicht | |
| ATE410161T1 (de) | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen | |
| ATE516286T1 (de) | 5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| ATE532518T1 (de) | Dipeptidyl-peptidase-hemmer zur behandlung von diabetes | |
| DK2049529T3 (da) | Substituerede diazepan-orexin-receptor- antagonister | |
| DE602007009095D1 (de) | Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| DE602006009968D1 (de) | N4-phenyl-chinazolin-4-aminderivate und verwandte verbindungen als inhibitoren der erbb-typ-i-rezeptortyrosinkinase zur behandlung hyperproliferativer krankheiten | |
| EP1838320A4 (de) | Cxcr4-antagonisten zur behandlung medizinischer probleme | |
| MY149855A (en) | Benzimidazole derivatives and their use for modulating the gaba? receptor complex | |
| JO2645B1 (en) | Vehicles | |
| NO20075074L (no) | Kinazolinon T-type-kalsiumkanalantagonister | |
| ATE512948T1 (de) | Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen | |
| NO20071272L (no) | Modulatorer av muskarine reseptorer. | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| ATE521365T1 (de) | Kinin-antagonisten zur behandlung von blasenfunktionsstörung | |
| MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
| DE602006006354D1 (de) | Pinolensäure zur Behandlung von Übergewicht | |
| NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
| MX2009008253A (es) | Derivados de 2-aminopiridina utiles como inhibidores de cinasa. | |
| DE502005010499D1 (de) | Implantat zur Behandlung von Fettsucht | |
| ATE450256T1 (de) | Verwendung von zusammensetzungen enthaltend kappa-opioidrezeptor-antagonisten zur behandlung von dissoziativen störungen | |
| ATE505468T1 (de) | N-gebundene heterocyclische antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |